Erythropoieis-stimulating Agents (ESAs) for Chronic Kidney Disease (CKD): With Active Cancer or a History of Cancer or Stroke

Erythropoiesis-stimulating agents (ESAs) are a group of medicines that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This pamphlet looks at this the risks and benefits of ESAs if you have/have had cancer or a stroke.